Sabine Ott

Sabine Ott is a seasoned professional in business development and licensing, currently serving as Senior Vice President at Revvity since May 2023, following the acquisition of Sirion. In their role at Revvity, Sabine supports SIRION and HORIZON. Prior to this, Sabine held positions at Horizon Discovery and SIRION BIOTECH GmbH, where responsibilities included out-licensing products and technologies for gene and cell therapy and establishing strategic partnerships. With extensive experience in the biotechnology sector, Sabine has also served in leadership roles at GeneWake GmbH, Klinikum der Universitaet Muenchen, and MWG Biotech AG. Sabine holds a Doctorate in Genetics from the University of Konstanz and a earlier degree from Ludwig-Maximilian University Munich.